Skip to main content

Table 2 Characteristics of patients who developed hepatocellular carcinoma during the initial 12 months of antiviral treatment

From: Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia

Baseline characteristics Patient 1 Patient 2 Patient 3
Sex F M M
Age 65 55 50
ALT, U/L 81 30 110
HBV viral load, IU/mL 75 13 10,100
Transient elastography, kPa 29.0 20.6 75.0
Co-infection (HCV/HDV) No No HDV
Co-morbidity No IDDM IDDM
Previous antiviral therapy No No No
Decompensated liver disease No Yes Yes
  1. ALT alanine aminotransferase, HBV hepatitis B virus, HCV hepatitis C virus, HDV hepatitis D virus, IDDM insulin-dependent diabetes mellitus